UniQure NV - Company Profile
Powered by
All the data and insights you need on UniQure NV in one report.
$295
- Save hours of research time and resources with
our up-to-date UniQure NV Strategy Report
- Understand UniQure NV position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on UniQure NV’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
22 Jun 2021 | uniQure to Acquire Corlieve Therapeutics | Acquisition |
UniQure NV
|
Corlieve Therapeutics SAS
|
01 Mar 2021 | uniQure to Raise up to USD200 Million in Public Offering of Shares | Equity Offering | - |
UniQure NV |
24 Jun 2020 | CSL Behring Enters into Licensing Agreement with uniQure | Licensing Agreement |
CSL Behring LLC
|
UniQure NV |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward